Daniela Ram
Overview
Explore the profile of Daniela Ram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perepliotchikov Y, Ziv-Baran T, Hindiyeh M, Manor Y, Sofer D, Moran-Gilad J, et al.
Vaccines (Basel)
. 2021 Aug;
9(8).
PMID: 34451995
Response to and monitoring of viral outbreaks can be efficiently focused when rapid, quantitative, kinetic information provides the location and the number of infected individuals. Environmental surveillance traditionally provides information...
2.
Kustin T, Ling G, Sharabi S, Ram D, Friedman N, Zuckerman N, et al.
Sci Rep
. 2019 Feb;
9(1):2606.
PMID: 30796243
Respiratory virus infections are very common. Such infections impose an enormous economic burden and occasionally lead to death. Furthermore, every few decades, respiratory virus pandemics emerge, putting the entire world...
3.
Jornist I, Muhsen K, Ram D, Lustig Y, Levy V, Orzitser S, et al.
J Clin Virol
. 2018 Aug;
107:19-24.
PMID: 30114677
Background: Human parainfluenza virus 3 (hPIV-3) causes respiratory tract infection. Objectives: The objective of this study was to describe the epidemiology of hPIV-3 infection among hospitalized patients and characterize the...
4.
Shirazi R, Ram D, Rakovsky A, Bucris E, Gozlan Y, Lustig Y, et al.
BMC Infect Dis
. 2018 Mar;
18(1):97.
PMID: 29486716
Background: Characteristics of hepatitis B (HBV) and delta (HDV) coinfection in various geographical regions, including Israel, remain unclear. Here we studied HDV seroprevalence in Israel, assessed HDV/HBV viral loads, circulating...
5.
Moscona R, Ram D, Wax M, Bucris E, Levy I, Mendelson E, et al.
J Int AIDS Soc
. 2017 Aug;
20(1):21846.
PMID: 28799325
Introduction: Transmitted drug-resistance mutations (TDRM) may hamper successful anti-HIV-1 therapy and impact future control of the HIV-1 epidemic. Recently infected, therapy-naïve individuals are best suited for surveillance of such TDRM....
6.
Manor Y, Lewis M, Ram D, Daudi N, Mor O, Savion M, et al.
J Infect Dis
. 2016 Dec;
215(4):574-580.
PMID: 28013247
Background: Universal toddlers vaccination (UTV) introduced in 1999, reduced hepatitis A incidence in Israel from 50.4 to <1.0/100,000. The current Hepatitis A virus (HAV) molecular epidemiology in Israel was studied...
7.
Weil M, Mandelboim M, Mendelson E, Manor Y, Shulman L, Ram D, et al.
J Clin Virol
. 2016 Dec;
86:52-55.
PMID: 27930928
Background: Since mid-August 2014, North America experienced a wide outbreak of Enterovirus D68 (EV-D68) associated with severe respiratory illness in children. Several other countries also reported cases of EV-D68 in...
8.
Ram D, Manor Y, Gozlan Y, Schwartz E, Ben-Ari Z, Mendelson E, et al.
Am J Trop Med Hyg
. 2016 Jun;
95(1):216-20.
PMID: 27246446
Hepatitis E virus (HEV) is an emerging infectious agent in developed countries. HEV genotypes 1 (G1) and 3 (G3) have been identified in environmental and clinical samples in Europe. In...
9.
Mor O, Bassal R, Michaeli M, Wax M, Ram D, Cohen-Ezra O, et al.
Emerg Infect Dis
. 2015 Mar;
21(4):692-4.
PMID: 25811302
We investigated prevalence of hepatitis E virus in a sample of the population of Israel. The overall seroprevalence of antibodies to the virus was 10.6% (95% CI 8.4%-13.0%); age-adjusted prevalence...
10.
Ram D, Leshkowitz D, Gonzalez D, Forer R, Levy I, Chowers M, et al.
J Virol Methods
. 2014 Dec;
212:12-6.
PMID: 25445792
Population HIV-1 sequencing is currently the method of choice for the identification and follow-up of HIV-1 antiretroviral drug resistance. It has limited sensitivity and results in a consensus sequence showing...